Efficacy of orally administered fluralaner (BravectoTM) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs

Overview of attention for article published in Parasites & Vectors, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter: 6 X users
patent: 2 patents

facebook: 9 Facebook pages
wikipedia: 5 Wikipedia pages

Citations

dimensions_citation: 80 Dimensions

Readers on

mendeley: 143 Mendeley

Summary X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

ISOXAZOLINE COMPOUNDS FOR USE IN TREATING DEMODICOSIS

Application EP-4008329-A1

European Patent Office

USE OF ISOXAZOLINE COMPOUNDS FOR TREATING DEMODICOSIS

Application WO-2016102437-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.